Kangaroo vs. porcine aortic valves: Calcification potential after glutaraldehyde fixation

European Surgical Research

Volumn 37, Issue 3, 2005, Pages 137-143

  Narine, K ^a,b   Chéry, Cyrille C ^a   Goetghebeur, Els ^a   Forsyth, R ^a   Claeys, E ^a   Cornelissen, Maria ^a   Moens, L ^a   Van Nooten, G ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aortic valves; Calcification; Kangaroo; Porcine

Indexed keywords

CALCIUM; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; ARTERY CALCIFICATION; ARTICLE; KANGAROO; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS FIXATION; RAT; SPECIES COMPARISON; SWINE;

ANIMALS; AORTIC VALVE; CALCINOSIS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FIXATIVES; GLUTARAL; HEART VALVE DISEASES; MACROPODIDAE; RATS; RATS, SPRAGUE-DAWLEY; SWINE; TISSUE FIXATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 23844510663     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085960     Document Type: Article

References (28)

1. Schoen FJ: Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc Pathol 1995;241-247.
2. Edmunds LH, Clarck RE, Cohn LH, Grunkemaier GL, Miller DC, Weisel RD: Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg 1996; 10: 812-816.
3. Kim KM, Herrera GA, Battarbee HD: Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol 1999; 154: 171.
4. Bortolotti U, Milano A, Mazzucco A: Results of reoperation for primary tissue failure of porcine bioprostheses. J Thorac Cardiovasc Surg 1985; 90: 564-568.
5. Carpentier SM, Monier M, Shen M, et al: Do donor or recipient species influence calcification of bioprosthetic tissues. Ann Thorac Surg 1995; 60:S328-8331.
6. Weinholdt C, Adt M, Weingartner J, et al: In vivo investigation of kangaroo aortic valve bioprostheses: An experimental animal model; in Bodnar E, Yacoub M (eds): Biological and Bioprosthetic Valves. Proc 3rd Int Symp, ed 1. London, Yorke Medical Books, 1986, pp 669-676.
7. Neethling WM, van Riet S, van den Heever JJ, Hough J, Hodge AJ: Evaluation of kangaroo aortic valves conduits in a juvenile sheep model. J Card Surg 2001; 16: 392-399.
8. Fishbein MC, Levy RJ, Ferrans VJ, Dearden LC, Nashef A, Goodman AP, Carpentier AP: Calcification of cardiac valve bioprostheses: Biochemical, histologic and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg 1982; 83: 602-609.
9. Schoen FJ, Levy RJ, Nelson AC, Bernard WF, Nashef A, Hawley M: Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985; 52:523-532.
10. Mako WJ, Vesely I: In vivo and in vitro models of calcification in porcine aortic valve cusps. J Heart Valve Dis 1997; 6: 316-323.
11. Carpentier SM, Carpentier AF, Cen L, Shen M, Quintero LJ, Witzel TH: Calcium mitigation in bioprosthetic tissues by iron pre-treatment: The challenge of iron leaching. Ann Thorac Surg 1995; 60:S332-S338.
12. Zuhdi N, Hancock W, Hawley W, Carey J, Greer A: Porcine aortic valves for replacement of human heart valves. J Cardiovasc Surg 1973; 8: 425-429.
13. Grabenwoger M, Sider J, Fitzal F, et al: Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg 1996; 62: 772-777.
14. Grabenwoger M, Grimm M, Eybl E, et al: New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardovasc Surg 1992; 104: 14-21.
15. Schoen FJ, Levy RJ: Bioprosthetic heart valve failure: Pathology and pathogenesis. Cardiol Clin 1984; 2: 717-739.
16. Levy RJ, Schoen FJ, Golomb G: Bioprosthetic heart valve calcification: Clinical features, pathobiology, and prospects for prevention. CRC Crit Rev Biocompat 1986; 2: 147-187.
17. Vyavahare N, Ogle M, Schoen FJ, Levy RJ: Elastin calcification and its prevention with aluminium chloride pretreatment. Am J Pathol 1999; 155: 973-982.
18. Guide for the Care and Use of Laboratory Animals. Bethesda, National Institutes of Health, Publ 85: 23, modified 85.
19. Vandecasteele C, Block CB: Modern Methods for Trace Element Determination. Chichester, Wiley, 1997.
20. Montaser A (ed): Inductively Coupled Mass Spectrometry. New York, Wiley-VCH, 1998.
21. Tan SH, Horlick G: Background spectral features in inductively coupled plasma mass spectrometry. Appl Spectrosc 1986; 40: 445-460.
22. Zilla P, Weissenstein C, Bracher M, Zhang Y, Koen W, Human P, von Oppel U: High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue. J Heart Valve Dis 1997; 6: 502-509.
23. Sabbah HN, Hamid MS, Stein PD: Mechanical stresses on closed cusps of porcine bioprosthetic valves: Correlation with sites of calcification. Ann Thorac Surg 1986; 42: 93-96.
24. Vyavahare N, Ogle M, Schoen F, Zand R, Gloeckner D. Claire, Sacks M, Levy R: Mechanisms of bioprosthetic heart valve failure: Fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999; 46: 44-50.
25. Van Nooten G, Ozaki S, Herrijgers P, Segers P, Vcrdonck P, Flameng W: Distortion of the stentless porcine valve induces accelerated leaflet fibrosis and calcification in juvenile sheep. J Heart Valve Dis 1999; 8: 34-41.
26. Meuris B, Ozaki S, Herijgers P, Verbeken E, Flameng W: Influence of species, environmental factors, and tissue cellularity on calcification of porcine aortic wall tissue. Semin Thorac Cardiovasc Surg 2001; 13(suppl 1):99-105.
27. Vesely I, Mako WJ: Comparison of the compressive buckling of porcine aortic valve cusps and bovine pericardium. J Heart Valve Dis 1998: 34-39.
28. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ: Inhibition of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: Preincubation and controlled release studies. J Biomed Mater Res 1993; 27: 1477-1484.